Hydrochlorothiazide Tablet
Product Images NDC 70518-4359

6 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 70518-4359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5828da2c 8c0c 4d0d 804a 32c20f1da2f2 01)

Image (5828da2c 8c0c 4d0d 804a 32c20f1da2f2 01)
Chemical structure of hydrochlorothiazide, showing a chlorinated benzothiadiazine ring with sulfonamide and other functional groups, consistent with the active ingredient in HYDROCHLOROTHIAZIDE 25 mg oral tablets by RemedyRepack Inc.*
FDA Label Image

Mm1 (Hydrochlorothiazide 25mg 70518 4359 00)

FDA Label Image

Mm2 (Hydrochlorothiazide 25mg 70518 4359 01)

FDA Label Image

Mm3 (Hydrochlorothiazide 25mg 70518 4359 02)

FDA Label Image

Mm4 (Hydrochlorothiazide 25mg 70518 4359 03)

FDA Label Image

Mm5 (Hydrochlorothiazide 25mg 70518 4359 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.